StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) KPIs and segments

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive GT Biopharma's business

Coming soon

This tab will track the numbers specific to GT Biopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?